|
| | Issue Date | Title | Author(s) |
| 1 | 21-Feb-2022 | Covid-19 in recipients of living donor liver transplantation: a worse or an equivalent outcome? | Salah, M; Dabbous, H M; Montasser, I.F. ; Bahaa, M. ; Abdou, A M H; Elmeteini, M S |
| 2 | 2022 | Plasma cell-rich acute rejection after living donor liver transplantation: Unusual or underestimated diagnosis? | Montasser, I.F. ; Ebada, H.; Faheem, H; Dabbous, H; Massoud, Y.; Salah, M.; Sakr, M.; Bahaa, M. ; Monayeri, M El; Meteini, M.El |
| 3 | Jan-2021 | Repeated COVID-19 infection in recipients of post-living donor liver transplantation: Two real-life cases | Montasser, I.F. ; Dabbous, H.M.; Salah, M.; Massoud, Y.; Ebada, H.; Sakr, M.; Atef, S.M. ; Bahaa, M. ; Mahmoud El-Meteini |
| 4 | 2019 | Non-Invasive Assessment of Graft Fibrosis After Living Donor Liver Transplantation: Is There Still a Role for Liver Biopsy? | Mahmoud El-Meteini ; Sakr, M.; Eldorry, A.; Mohran, Z.; Abdelkader, N.A.; Dabbous, H.; Montasser, I.F. ; Refaie, R.; Salah, M.; Aly, M. |
| 5 | 2017 | Role of microRNA-7 and selenoprotein P in hepatocellular carcinoma | Tarek, M. ; Louka, M.L. ; Khairy, E. ; Ali-Labib, R. ; Zaky, D.Z. ; Montasser, I.F. |
| 6 | Apr-2014 | Optimizing outcome of recurrent hepatitis C virus genotype 4 after living donor liver transplantation: moving forward by looking back | Dabbous, H M; Mahmoud El-Meteini ; Sakr, M A; Montasser, I.F. ; Bahaa, M. ; Abdelaal, A; Fathy, M; Refaie, R; Seyam, M; Abdelmonem, A; Mukhtar, A; Hegazy, N; Almoneiri, M |
Loading...
2
0
20
0
false